Gloria B. Chiu, OD, FAAO, FSLS

Chiu discusses factors affecting adoption of the FDA-approved epi-on therapy, from clinic setup to insurance coverage, while highlighting its safety and efficacy.

Equally important is that any symptoms of ocular allergies should be addressed to reduce the frequency of eye rubbing.